Who owns Kiniksa Pharmaceuticals Ltd?
- CUSIP Number: g5269c101
Tip: Access positions for across all investors
Analyze quarterly positions in Kiniksa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kiniksa Pharmaceuticals stock
Who bought or sold Kiniksa Pharmaceuticals Ltd this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Harbor Capital Advisors | 98k | $2.4M | 100% | Sep 2024 |
|
| Birchview Capital | 30k | $750k | 0% | Sep 2024 |
|
Who sold out of Kiniksa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Mar 2024 | 4.2M | $83M |
| Vanguard Group | Mar 2024 | 3.0M | $59M |
| State Street Corporation | Mar 2024 | 1.9M | $37M |
| Pictet Asset Management Holding SA | Mar 2024 | 1.5M | $29M |
| Morgan Stanley | Mar 2024 | 1.3M | $25M |
| Nuveen Asset Management | Mar 2024 | 831k | $16M |
| Goldman Sachs Group | Mar 2024 | 760k | $15M |
| Parkman Healthcare Partners | Mar 2024 | 646k | $13M |
| Northern Trust | Mar 2024 | 291k | $5.7M |
| Rafferty Asset Management | Mar 2024 | 141k | $2.8M |
| Lion Point Capital | Mar 2024 | 131k | $2.6M |
| Qube Research & Technologies | Mar 2024 | 129k | $2.5M |
| Sei Investments | Mar 2024 | 74k | $1.5M |
| Martingale Asset Management | Mar 2024 | 45k | $895k |
| Tejara Capital | Mar 2024 | 43k | $842k |
| Capula Management | Mar 2024 | 41k | $814k |
| Alliancebernstein | Mar 2024 | 40k | $781k |
| Barclays | Jun 2024 | 35k | $650k |